Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020

Cancers (Basel). 2021 Feb 24;13(5):947. doi: 10.3390/cancers13050947.

Authors

Jonas Cicenas^{1

2}, Asta Račienė³

Affiliations

¹ Proteomics Center, Institute of Biochemistry, Vilnius University Life Sciences Center, Sauletekio al. 7, LT-10257 Vilnius, Lithuania.
² MAP Kinase Resource, Bioinformatics, Melchiorstrasse 9, CH-3027 Bern, Switzerland.
³ Vilnius University Hospital, Santariskiu Klinikos Santariskiu str. 2, LT-08661 Vilnius, Lithuania.

Abstract

Cancers are a large group of diseases that mostly emerge because of the uncontrollable action of many different genes in human cells [...].

Publication types

Editorial